The Food and Drug Administration (FDA) has approved Dulera®  (mometasone furoate and formoterol fumarate dehydrate) Inhalation Aerosol (Merck & Co.) for patients 12 years and older. Dulera combines an inhaled corticosteroid with a long-acting bronchodilator. It is available in a metered-dose inhaler with a dose counter. Dulera is not indicated for the relief of acute bronchospasm.

First published Allergy & Asthma Today, Fall 2010, Volume 8, Issue 3

For AANMA’s complete chart of asthma medications, click here.

Related posts:

1. FDA Confirms New Label Language for Medications Containing Long-Acting Beta Agonists (LABAs)
2. Nasal Allergies? Sniff This!
3. Secondhand Smoke Disturbs Sleep
4. Pinpoint Peanut Allergy